Moreover, the development of myocarditis in patients with cancer treated with immune checkpoint inhibitors underscores the severe immunopathological damage caused by unleashing both CD4+ and CD8+ T cell reactivity against self-antigens in the cardiac microenvironment12–15. Here, CD4 is linked to myocarditis.